| All Releases |
 |
May 4, 2012
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2012 |
 |
 |
| |
DUBLIN, Ireland, May 4, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended March 31, 2012.
Total revenue in the quarter ended March 31, 2012 was $685 million, a decrease of $72 million, or 10%, compared to the quarter ended March 31, 2011. For the quarter ended March 31, 2012, the decrea... |
|
|
May 1, 2012
Announcement Under Irish Takeover Rules Relevant Securities in Issue |
|
|
| |
DUBLIN, Ireland, May 1, 2012 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "Company") confirms that, as of the close of business on April 30, 2012, the Company's issued share capital consisted of 250,421,544 ordinary shares, par value US$0.01 per share (the "Ordinary Shares"). T... |
|
|
April 30, 2012
Warner Chilcott Announces Decision in Doryx Patent Litigation |
|
|
| |
DUBLIN, Ireland, April 30, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the U.S. District Court for the District of New Jersey upheld the validity of the U.S. patent covering the Company's DORYX 150 mg product (the "'161 Patent"), but determined that neither Mylan Inc.'s (together with its affiliate Mylan Pharmace... |
|
|
April 30, 2012
Review of Strategic Alternatives |
|
|
| |
DUBLIN, April 30, 2012 (GLOBE NEWSWIRE) -- Further to media speculation, the Board of Warner Chilcott plc (Nasdaq:WCRX) confirmed today that it is conducting a process to explore a broad range of strategic alternatives to enhance shareholder value, which include preliminary discussions with potential offerors.
These discussions are at a prelimi... |
|
|
April 26, 2012
Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2012 Financial Results |
|
|
| |
DUBLIN, Ireland, April 26, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its first quarter 2012 financial results prior to the market opening on Friday, May 4, 2012.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, May 4, 2012 at... |
|
|
April 25, 2012
Warner Chilcott to Present at the Goldman Sachs Leveraged Finance Conference 2012 |
|
|
| |
DUBLIN, Ireland, April 25, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to speak at the Goldman Sachs Leveraged Finance Conference 2012 on Tuesday, May 1st at 3:30 p.m. EDT.
The presentation will be simultaneously webcast at... |
|
|
February 24, 2012
Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2011 |
|
|
| |
DUBLIN, Ireland, Feb. 24, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter and year ended December 31, 2011. Our results of operations in the quarter ended December 31, 2011 as compared to the prior year quarter were impacted by several important transactions. In 2011, these transactions include... |
|
|
February 22, 2012
Warner Chilcott to Present at the 2012 RBC Capital Markets' Healthcare Conference |
|
|
| |
DUBLIN, Ireland, Feb. 22, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to speak at the 2012 RBC Capital Markets' Healthcare Conference on Wednesday, February 29th at 1:30 p.m. EST.
The presentation will be simultaneously web... |
|
|
February 21, 2012
Warner Chilcott to Present at the 2012 Citi Global Health Care Conference |
|
|
| |
DUBLIN, Ireland, Feb. 21, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to speak at the 2012 Citi Global Health Care Conference on Tuesday, February 28th at 2:00 p.m. EST.
The presentation will be simultaneously webcast at ht... |
|
|
February 17, 2012
Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2011 Financial Results |
|
|
| |
DUBLIN, Ireland, Feb. 17, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its fourth quarter and full year 2011 financial results prior to the market opening on Friday, February 24, 2012.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Fr... |
|
|
January 27, 2012
Warner Chilcott Announces 2012 Financial Guidance |
|
|
| |
DUBLIN, Ireland, Jan. 27, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) announced today its view of anticipated full year 2012 results.
Total revenue for 2012 is expected to be in the range of $2.5 to $2.6 billion. The 2012 revenue expectations reflect, among other things, the anticipated growth of the Company's promoted products i... |
|
|
January 24, 2012
Warner Chilcott Announces 2012 Financial Guidance Conference Call |
|
|
| |
DUBLIN, Ireland, Jan. 24, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its 2012 financial guidance prior to the market opening on Friday, January 27, 2012.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, January 27, 2012 at 8:0... |
|
|
January 4, 2012
Warner Chilcott to Present at the 30th Annual J.P. Morgan Healthcare Conference |
|
|
| |
DUBLIN, Ireland, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its President, Europe/International and Global Marketing, Hans Van Zoonen, and its Executive Vice President and Chief Financial Officer, Paul Herendeen, are scheduled to speak at the 30th Annual J.P. Morgan Healthcare Conference on Tuesday, Janu... |
|
|
December 12, 2011
Warner Chilcott Announces Decision on Appeal of DORYX Preliminary Injunction |
|
|
| |
DUBLIN, Ireland, Dec. 12, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the U.S. Court of Appeals for the Federal Circuit vacated a preliminary injunction granted by the U.S. District Court for the District of New Jersey against Mylan Inc. and its affiliate Mylan Pharmaceuticals Inc. (together "Mylan") and remanded... |
|
|
December 2, 2011
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition |
|
|
| |
DUBLIN, Ireland, Dec. 2, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it has received the Food and Drug Administration's ("FDA's") response to a citizen petition that it filed regarding its ASACOL and ASACOL HD products. In its petition, Warner Chilcott requested that the FDA confirm that it will require applicant... |
|
|
November 9, 2011
Warner Chilcott Announces Program to Redeem Up to $250 Million of Its Ordinary Shares |
|
|
| |
DUBLIN, Ireland, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors has authorized the redemption of up to an aggregate of $250 million of its ordinary shares (the "Redemption Program"). The Company expects to fund the Redemption Program with cash generated from operations.
The Company... |
|
|
November 4, 2011
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2011 |
|
|
| |
DUBLIN, Ireland, Nov. 4, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended September 30, 2011. Our results of operations in the quarter and nine months ended September 30, 2011 as compared to the prior year periods were impacted by several important transactions. In 2011, these transactions... |
|
|
October 21, 2011
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter Financial Results |
|
|
| |
DUBLIN, Ireland, Oct. 21, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its third quarter financial results prior to the market opening on Friday, November 4, 2011.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, November 4, 201... |
|
|
September 22, 2011
Warner Chilcott Announces Favorable Decision in DORYX Preliminary Injunction Proceedings |
|
|
| |
DUBLIN, Ireland, Sept. 22, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the U.S. District Court for the District of New Jersey granted its motion for a preliminary injunction against Mylan Inc. and its affiliate Mylan Pharmaceuticals Inc. (together "Mylan"). The preliminary injunction prevents Mylan from launching... |
|
|
September 13, 2011
Warner Chilcott to Present at the UBS Global Life Sciences Conference |
|
|
| |
DUBLIN, Ireland, Sept. 13, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the UBS Global Life Sciences Conference on Monday, September 19th at 1:30 p.m. EDT.
The presentation will be simultaneously webcast at http://... |
|
|
|
Investor Relations
